Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Alliqua Biomedical Inc    ALQA

ALLIQUA BIOMEDICAL INC (ALQA)
Mes dernières consult.
Most popular
  Report  
 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Financials (USD)
Sales 2018 22,0 M
EBIT 2018 -13,2 M
Net income 2018 -19,7 M
Debt 2018 -
Yield 2018 -
Sales 2019 26,5 M
EBIT 2019 -9,00 M
Net income 2019 -15,5 M
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 0,50x
Capi. / Sales2019 0,42x
Capitalization 11,0 M
More Financials
Company
Alliqua BioMedical, Inc. is a regenerative technologies company, which commercializes differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue.The firm builds a suite of technological solutions that allow clinicians to utilize the latest... 
More about the company
Latest news on ALLIQUA BIOMEDICAL INC
04/06CELLECTAR BIOSCIENCES : Appoints Brian M. Posner as Chief Financial Officer
AQ
04/05CELLECTAR BIOSCIENCES : Appoints Brian M. Posner as Chief Financial Officer
AQ
03/16ALLIQUA BIOMEDICAL, INC. (NASDAQ : ALQA) Files An 8-K Entry into a Material Defi..
AQ
03/15ALLIQUA BIOMEDICAL, INC. : Entry into a Material Definitive Agreement, Creation ..
AQ
03/02ALLIQUA BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
AQ
02/09ALLIQUA BIOMEDICAL, INC. : Entry into a Material Definitive Agreement, Financial..
AQ
01/11ALLIQUA BIOMEDICAL : 65-- Ultramist Ultrasound Therapy
AQ
01/09ALLIQUA BIOMEDICAL : W-- Lease Renewal for Ultra-Mist Therapy Systems
AQ
01/09ALLIQUA BIOMEDICAL INC : Wired News – Alliqua BioMedical Enters into Purchase Ag..
AC
01/09ALLIQUA BIOMEDICAL : Haynes and Boone Represents Alliqua in $29 Million Transact..
AQ
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
04/19China May Request Minor Restrictions for Essilor Merger, Says Luxottica Chair..
DJ
04/19LUXOTTICA : chairman says China may seek 'minor restrictions' to clear Essilor d..
RE
04/04Smith & Nephew picks new CEO who sold his last company
RE
03/12Sensirion, Medartis to raise cash in Swiss IPO boom
RE
03/12STRAUMANN : Medartis to use IPO proceeds to expand amid rising implant demand
RE
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
2017Midday Gainers / Losers 
2017HEALTHCARE - TOP 5 GAINERS / LOSERS : 15 pm 
2017ALLIQUA BIO'S 1 : 10 reverse split effective today; shares off 10% 
2017FDA clears Alliqua BioMedical's SilverSeal wound dressing; shares up 32% 
2017Alliqua BioMedical's (ALQA) CEO Dave Johnson on Q2 2017 Results - Earnings Ca.. 
Chart ALLIQUA BIOMEDICAL INC
Duration : Period :
Alliqua Biomedical Inc Technical Analysis Chart | ALQA | US0196212007 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus HOLD
Number of Analysts 1
Average target price 2,80 $
Spread / Average Target 28%
EPS Revisions
Managers
NameTitle
David Ian Johnson President, Chief Executive Officer & Director
Bradford C. Barton Chief Operating Officer
Joseph Michael Warusz Chief Financial Officer
Joseph M. Leone Independent Director
Jeffrey Sklar Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ALLIQUA BIOMEDICAL INC-52.37%11
MEDTRONIC PLC-0.90%108 457
BAXTER INTERNATIONAL3.93%36 130
ZIMMER BIOMET HOLDINGS-9.31%22 602
TERUMO CORP11.90%20 657
HOYA CORPORATION1.99%20 360